BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 19958580)

  • 1. Electrostatics of pharmaceutical inhalation aerosols.
    Kwok PC; Chan HK
    J Pharm Pharmacol; 2009 Dec; 61(12):1587-99. PubMed ID: 19958580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrostatics of Pharmaceutical Aerosols for Pulmonary Delivery.
    Lip Kwok PC
    Curr Pharm Des; 2015; 21(27):3945-54. PubMed ID: 26290198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of particle properties in pharmaceutical powder inhalation formulations.
    Chew NY; Chan HK
    J Aerosol Med; 2002; 15(3):325-30. PubMed ID: 12396421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dry powder aerosol delivery systems: current and future research directions.
    Chan HK
    J Aerosol Med; 2006; 19(1):21-7. PubMed ID: 16551211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics.
    Hickey AJ; Mansour HM; Telko MJ; Xu Z; Smyth HD; Mulder T; McLean R; Langridge J; Papadopoulos D
    J Pharm Sci; 2007 May; 96(5):1302-19. PubMed ID: 17455364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurements of electrodynamic effects on the deposition of MDI and DPI aerosols in a replica cast of human oral-pharyngeal-laryngeal airways.
    Ali M; Mazumder MK; Martonen TB
    J Aerosol Med Pulm Drug Deliv; 2009 Mar; 22(1):35-44. PubMed ID: 18800879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical aerosol electrostatics: a field with much potential for development.
    Lip Kwok PC
    Ther Deliv; 2015 Feb; 6(2):105-7. PubMed ID: 25690079
    [No Abstract]   [Full Text] [Related]  

  • 8. The nanoscale in pulmonary delivery. Part 2: formulation platforms.
    Rogueda PG; Traini D
    Expert Opin Drug Deliv; 2007 Nov; 4(6):607-20. PubMed ID: 17970664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosol electrostatics. I: Properties of fine powders before and after aerosolization by dry powder inhalers.
    Byron PR; Peart J; Staniforth JN
    Pharm Res; 1997 Jun; 14(6):698-705. PubMed ID: 9210184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrostatics in pharmaceutical aerosols for inhalation.
    Wong J; Chan HK; Kwok PC
    Ther Deliv; 2013 Aug; 4(8):981-1002. PubMed ID: 23919475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of triboelectric charging in dry powder inhalers using electrical low pressure impactor (ELPI).
    Telko MJ; Kujanpää J; Hickey AJ
    Int J Pharm; 2007 May; 336(2):352-60. PubMed ID: 17218072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of dry powder inhalers.
    Chougule MB; Padhi BK; Jinturkar KA; Misra A
    Recent Pat Drug Deliv Formul; 2007; 1(1):11-21. PubMed ID: 19075871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Inhalers Deliver Very Small Doses to the Lower Tracheobronchial Airways: Assessment of Healthy and Constricted Lungs.
    Walenga RL; Longest PW
    J Pharm Sci; 2016 Jan; 105(1):147-59. PubMed ID: 26852850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring Bipolar Charge and Mass Distributions of Powder Aerosols by a Novel Tool (BOLAR).
    Wong J; Lin YW; Kwok PC; Niemelä V; Crapper J; Chan HK
    Mol Pharm; 2015 Sep; 12(9):3433-40. PubMed ID: 26222019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
    Li X; Vogt FG; Hayes D; Mansour HM
    Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the role of particle morphology in pharmaceutical powder aerosols?
    Chan HK
    Expert Opin Drug Deliv; 2008 Aug; 5(8):909-14. PubMed ID: 18712999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Powder Production and Particle Engineering for Dry Powder Inhaler Formulations.
    Lin YW; Wong J; Qu L; Chan HK; Zhou QT
    Curr Pharm Des; 2015; 21(27):3902-16. PubMed ID: 26290193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary drug delivery by powder aerosols.
    Yang MY; Chan JG; Chan HK
    J Control Release; 2014 Nov; 193():228-40. PubMed ID: 24818765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers.
    Buttini F; Miozzi M; Balducci AG; Royall PG; Brambilla G; Colombo P; Bettini R; Forbes B
    Int J Pharm; 2014 Apr; 465(1-2):42-51. PubMed ID: 24491530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary vaccine delivery.
    Lu D; Hickey AJ
    Expert Rev Vaccines; 2007 Apr; 6(2):213-26. PubMed ID: 17408371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.